← Back to headlines
Insilico Partners with SK Biopharmaceuticals in $2.5B AI Drug Pact
Insilico Medicine has partnered with SK Biopharmaceuticals in a significant $2.5 billion agreement focused on AI-driven drug discovery.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Nigeria’s Oil Regulator Threatens Sanctions Over Idle Gas Flare Sites
35m ago
South Korean Gaming Tycoon Ordered to Pay Record $1.87 Billion Divorce Settlement
1h ago
Caleres Reports Q2 Earnings Beat Driven by Brand Portfolio Growth
1h ago
Nigerian Army Redeploys Senior Generals and Reshuffles Leadership
1h ago